Published in N Engl J Med on October 08, 1981
Evidence of a causal role of winter virus infection during infancy in early childhood asthma. Am J Respir Crit Care Med (2008) 3.84
Viral and host factors in human respiratory syncytial virus pathogenesis. J Virol (2007) 3.19
Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years. Virus Res (2011) 2.51
Identification of NF-kappaB-dependent gene networks in respiratory syncytial virus-infected cells. J Virol (2002) 1.97
Rhinovirus upper respiratory infection increases airway hyperreactivity and late asthmatic reactions. J Clin Invest (1989) 1.97
Detection, pathogenesis, and therapy of respiratory syncytial virus infections. Clin Microbiol Rev (1988) 1.92
Respiratory virus infections and aeroallergens in acute bronchial asthma. Arch Dis Child (1984) 1.89
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Expression of respiratory syncytial virus-induced chemokine gene networks in lower airway epithelial cells revealed by cDNA microarrays. J Virol (2001) 1.88
Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1alpha in lung pathology. J Virol (2001) 1.88
Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment. Clin Microbiol Rev (1999) 1.83
Outcome of acute lower respiratory tract infection in infants: preliminary report of seven-year follow-up study. Br Med J (Clin Res Ed) (1982) 1.66
Importance of respiratory viruses in acute otitis media. Clin Microbiol Rev (2003) 1.60
Symptoms, atopy, and bronchial reactivity after lower respiratory infection in infancy. Arch Dis Child (1984) 1.59
Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus. J Virol (1997) 1.55
Respiratory syncytial virus induces interleukin-10 by human alveolar macrophages. Suppression of early cytokine production and implications for incomplete immunity. J Clin Invest (1995) 1.47
Increases in plasma concentrations of a prostaglandin metabolite in acute airway obstruction. Arch Dis Child (1989) 1.38
Chemotherapy of rhinovirus colds. Antimicrob Agents Chemother (1988) 1.30
Adults 65 years old and older have reduced numbers of functional memory T cells to respiratory syncytial virus fusion protein. Clin Vaccine Immunol (2012) 1.17
The microbiology of asthma. Nat Rev Microbiol (2012) 1.14
Host immune responses to rhinovirus: mechanisms in asthma. J Allergy Clin Immunol (2008) 1.14
Quantitation of immunoglobulin E antibody to cytomegalovirus by antibody capture enzyme-linked immunosorbent assay. J Clin Microbiol (1985) 1.12
Mechanisms of virus induced exacerbations of asthma. Thorax (1997) 1.12
Acute and long-term effects of viral bronchiolitis in infancy. Lung (1990) 1.09
Respiratory syncytial virus infection suppresses IFN-gamma production of gammadelta T cells. Clin Exp Immunol (2003) 1.07
Interleukin-4 diminishes CD8(+) respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo. J Virol (1999) 1.05
Virus-induced airway hyperresponsiveness in guinea pigs is related to a deficiency in nitric oxide. J Clin Invest (1995) 1.01
Responsiveness to respiratory syncytial virus in neonates is mediated through thymic stromal lymphopoietin and OX40 ligand. J Allergy Clin Immunol (2012) 0.99
Tissue distribution of mucosal antibody-producing cells specific for respiratory syncytial virus in severe combined immune deficiency (SCID) mice engrafted with human tonsils. Clin Exp Immunol (1991) 0.99
Respiratory syncytial virus-specific antibody responses in immunoglobulin A and E isotypes to the F and G proteins and to intact virus after natural infection. J Clin Microbiol (1989) 0.95
Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice. PLoS One (2012) 0.93
Evaluation of immunoglobulin E-specific antibodies and viral antigens in nasopharyngeal secretions of children with respiratory syncytial virus infections. J Clin Microbiol (1993) 0.91
Antibody enhancement of respiratory syncytial virus stimulation of leukotriene production by a macrophagelike cell line. J Virol (1991) 0.91
Atopy and house dust mite sensitization as risk factors for asthma in children. Yonsei Med J (2005) 0.89
Th17 lymphocytes in respiratory syncytial virus infection. Viruses (2013) 0.88
Development of asthma is determined by the age-dependent host response to respiratory virus infection: therapeutic implications. Curr Opin Immunol (2012) 0.86
Double-stranded RNA-activated protein kinase regulates early innate immune responses during respiratory syncytial virus infection. J Interferon Cytokine Res (2010) 0.85
Induction of humoral immunity and pulmonary mast cells in mice and rats after immunization with aerosolized antigen. Immunology (1983) 0.85
Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis. Arch Dis Child (1995) 0.84
Virus-induced airway hyperresponsiveness in the guinea-pig: possible involvement of histamine and inflammatory cells. Br J Pharmacol (1993) 0.83
The Role of RSV Infection in Asthma Initiation and Progression: Findings in a Mouse Model. Pulm Med (2011) 0.83
Long term persistence of IgE anti-influenza virus antibodies in pediatric and adult serum post vaccination with influenza virus vaccine. Int J Med Sci (2011) 0.83
Long Term Persistence of IgE Anti-Varicella Zoster Virus in Pediatric and Adult Serum Post Chicken Pox Infection and after Vaccination with Varicella Virus Vaccine. Int J Biomed Sci (2009) 0.81
Cellular and humoral immunity of virus-induced asthma. Front Microbiol (2013) 0.81
Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses. Thorax (1998) 0.81
Development of local immunity: role in mechanisms of protection against or pathogenesis of respiratory syncytial viral infections. Lung (1990) 0.80
Nasal IgA response in wheezy infants. Arch Dis Child (1993) 0.79
Airway IFN-γ production during RSV bronchiolitis is associated with eosinophilic inflammation. Lung (2011) 0.79
Why do viruses make infants wheeze? Arch Dis Child (1996) 0.79
Latent sensitisation to respiratory syncytial virus during acute bronchiolitis and lung function after recovery. Arch Dis Child (1990) 0.78
Dendritic cells, viruses, and the development of atopic disease. J Allergy (Cairo) (2012) 0.78
Economic and long-term benefits of ribavirin therapy on respiratory syncytial virus infection. Lung (1990) 0.76
Role of viruses in the development of atopic disease in pediatric patients. Curr Allergy Asthma Rep (2012) 0.76
The Human Immune Response to Respiratory Syncytial Virus Infection. Clin Microbiol Rev (2017) 0.75
Environmental risk factors and their role in the management of atopic dermatitis. Expert Rev Clin Immunol (2016) 0.75
Blood histamine levels (BHL) in infants and children with respiratory and non-respiratory diseases. Mediators Inflamm (2001) 0.75
Need for a safe vaccine against respiratory syncytial virus infection. Korean J Pediatr (2012) 0.75
Infection, eosinophilia and childhood asthma. Asia Pac Allergy (2012) 0.75
Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group. N Engl J Med (1993) 5.67
Recognition and management of difficult airway problems. Br J Anaesth (1992) 3.69
Distribution of poliovirus antibody in serum, nasopharynx and alimentary tract following segmental immunization of lower alimentary tract with poliovaccine. J Immunol (1969) 3.49
Effect of tonsillectomy and adenoidectomy on nasopharyngeal antibody response to poliovirus. N Engl J Med (1971) 3.13
BioMart Central Portal: an open database network for the biological community. Database (Oxford) (2011) 3.03
Simulated difficult intubation. Comparison of the gum elastic bougie and the stylet. Anaesthesia (1996) 2.84
Airways revisited. Br J Anaesth (1989) 2.81
Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol (1998) 2.71
Airway management before, during and after extubation: a survey of practice in the United Kingdom and Ireland. Anaesthesia (2005) 2.68
Cervical screening and health inequality in England in the 1990s. J Epidemiol Community Health (2003) 2.67
Antibody response in serum and nasopharynx after naturally acquired and vaccine-induced infection with rubella virus. N Engl J Med (1971) 2.62
Evaluation of the use of the Flexiblade. Anaesthesia (2000) 2.59
Lymphocyte blast transformation. I. Demonstration of adrenergic receptors in human peripheral lymphocytes. Cell Immunol (1970) 2.58
Frequent activation of AKT2 and induction of apoptosis by inhibition of phosphoinositide-3-OH kinase/Akt pathway in human ovarian cancer. Oncogene (2000) 2.55
Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer. J Clin Oncol (1999) 2.38
Calcium and the anaesthetist. Anaesthesia (2000) 2.36
The distance between the grille of the laryngeal mask airway and the vocal cords. Is conventional intubation through the laryngeal mask safe? Anaesthesia (1993) 2.33
Local antibody response to poliovaccine in the human female genital tract. J Immunol (1973) 2.30
Epidemic measles in young adults. Clinical, epidemiologic, and serologic studies. Ann Intern Med (1979) 2.29
Pain relief after thoracotomy. Br J Anaesth (2001) 2.27
Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice. Pediatr Res (1993) 2.22
Sales of nonprescription cold remedies: a unique method of influenza surveillance. Pediatr Res (1979) 2.22
Radioreceptor binding profile of the atypical antipsychotic olanzapine. Neuropsychopharmacology (1996) 2.18
Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol (2011) 2.18
Problems associated with tracheal extubation. Br J Anaesth (1993) 2.13
Fractured laryngeal mask airway (LMA). Can J Anaesth (2000) 2.12
The pharmacologic profile of fluoxetine. J Clin Psychiatry (1985) 2.04
Anaesthesia for telescopic procedures in the thorax. Br J Anaesth (1998) 2.02
Osteogenic sarcoma with clinically detectable metastasis at initial presentation. J Clin Oncol (1993) 2.01
Mechanism of action of camptothecin. Ann N Y Acad Sci (2000) 2.01
Intensity-modulated radiation therapy leads to survival benefit only in patients with high-risk prostate cancer: a population-based study. Ann Oncol (2014) 1.98
Vaccination strategies for mucosal immune responses. Clin Microbiol Rev (2001) 1.98
An improved spectrophotometric assay for superoxide dismutase based on epinephrine autoxidation. Anal Biochem (1978) 1.97
Antagonists agree on pesticide law reform. Science (1986) 1.95
A selective inhibitor of serotonin uptake: Lilly 110140, 3-(p-trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine. Life Sci (1974) 1.93
Respiratory syncytial virus. Curr Probl Pediatr (1993) 1.93
Respiratory syncytial virus infection. Rapid diagnosis in children by use of indirect immunofluorescence. Am J Dis Child (1978) 1.90
Poliovirus antibody response in serum and nasal secretions following intranasal inoculation with inactivated poliovaccine. J Immunol (1969) 1.90
Cell-specific expression of RANTES, MCP-1, and MIP-1alpha by lower airway epithelial cells and eosinophils infected with respiratory syncytial virus. J Virol (1998) 1.88
Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology (2001) 1.88
Changes in nasopharyngeal flora during otitis media of childhood. Pediatr Infect Dis J (1990) 1.88
Jaw thrusting as a clinical test to assess the adequate depth of anaesthesia for insertion of the laryngeal mask. Anaesthesia (1996) 1.86
Potential spectrum of etiological agents of viral enteritis in hospitalized infants. J Clin Microbiol (1983) 1.85
Macrophage inflammatory protein-1alpha (not T helper type 2 cytokines) is associated with severe forms of respiratory syncytial virus bronchiolitis. J Infect Dis (2001) 1.78
Immunologic properties of RA27-3 rubella virus vaccine. A comparison with strains presently licensed in the United States. JAMA (1973) 1.73
Effect of prior immunity on the shedding of virulent revertant virus in feces after oral immunization with live attenuated poliovirus vaccines. J Infect Dis (1991) 1.72
Stimulation of leukocyte adenyl cyclase by hydrocortisone and isoproterenol in asthmatic and nonasthmatic subjects. J Allergy Clin Immunol (1972) 1.71
Trichomonas vaginalis and cervical cancer. A prospective study in China. Ann Epidemiol (1995) 1.71
Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J Pediatr (1992) 1.70
Immunologic aspects of human colostrum and milk. III. Fate and absorption of cellular and soluble components in the gastrointestinal tract of the newborn. J Immunol (1977) 1.69
STAT3 participates in transcriptional activation of the C-reactive protein gene by interleukin-6. J Biol Chem (1996) 1.68
Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization. Biotechniques (2000) 1.68
Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis. Oncogene (2001) 1.67
A quantitative assessment of how Canadian intensivists believe they utilize oxygen in the intensive care unit. Crit Care Med (1999) 1.66
Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr (1996) 1.65
Respiratory complications associated with tracheal intubation and extubation. Br J Anaesth (1998) 1.64
Vancomycin anaphylaxis and successful desensitization. Ann Allergy (1994) 1.64
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses. J Pediatr (1980) 1.63
The neurogenetics of mucolipidosis type IV. Neurology (2002) 1.62
Nasopharyngeal flora in the first three years of life in normal and otitis-prone children. Ann Otol Rhinol Laryngol (1991) 1.60
Adenocarcinomas of the esophagus and gastric cardia: the role of diet. Nutr Cancer (1997) 1.59
Accessory cell function of human eosinophils. HLA-DR-dependent, MHC-restricted antigen-presentation and IL-1 alpha expression. J Immunol (1993) 1.57
Autonomic imbalance in asthma with special reference to beta adrenergic blockade. Adv Intern Med (1972) 1.56
Otitis media in children. I. The systemic immune response to nontypable Hemophilus influenzae. J Infect Dis (1989) 1.55
Cell cycle dysregulation in oral cancer. Crit Rev Oral Biol Med (2002) 1.54
Rubella-virus infection in juvenile rheumatoid arthritis. Lancet (1975) 1.52
Arthritis associated with induced rubella infection. J Immunol (1971) 1.51
Comprehensive analysis of 112 melanocytic skin lesions demonstrates microsatellite instability in melanomas and dysplastic nevi, but not in benign nevi. J Cutan Pathol (2001) 1.51
Saliva: diagnostics and therapeutic perspectives. Oral Dis (2010) 1.50
A comparison of peribulbar and retrobulbar anesthesia for vitreoretinal surgical procedures. Arch Ophthalmol (1995) 1.49
Extended pelvic lymph node dissection in prostate cancer: a 20-year audit in a single center. Ann Oncol (2013) 1.49
Improving energy expenditure estimation by using a triaxial accelerometer. J Appl Physiol (1985) (1997) 1.49
SUMO-1 conjugation to topoisomerase I: A possible repair response to topoisomerase-mediated DNA damage. Proc Natl Acad Sci U S A (2000) 1.47
Training in fibreoptic laryngoscopy. Br J Anaesth (1991) 1.46
Free radical scavenging and antioxidant activity of plant flavonoids. Adv Exp Med Biol (1994) 1.45
Immunologic aspects of human colostrum and milk. II. Characteristics of lymphocyte reactivity and distribution of E-rosette forming cells at different times after the onset of lactation. J Pediatr (1978) 1.44
The control of post-thoracotomy pain. A comparative evaluation of thoracic epidural fentanyl infusions and cryo-analgesia. Anaesthesia (1988) 1.44
Human saliva proteome and transcriptome. J Dent Res (2006) 1.43
The cuffed oropharyngeal airway. Its clinical use in 100 patients. Anaesthesia (1998) 1.43
Effect of food on hepatic blood flow: implications in the "food effect" phenomenon. Clin Pharmacol Ther (1983) 1.43
Antiviral effect of flavonoids on human viruses. J Med Virol (1985) 1.43
Aerobic fitness, not energy expenditure, influences subsequent increase in adiposity in black and white children. Pediatrics (2000) 1.43
The anatomical and biochemical basis of bronchial obstruction in asthma. Ann Intern Med (1965) 1.42
Comparative human salivary and plasma proteomes. J Dent Res (2010) 1.41
Misuse of the laryngeal mask airway. Anaesthesia (1994) 1.41
Intragenic mutation analysis of the human epidermal growth factor receptor (EGFR) gene in malignant human oral keratinocytes. Cancer Res (1999) 1.40
Effect of enhanced ultraviolet germicidal irradiation in the heating ventilation and air conditioning system on ventilator-associated pneumonia in a neonatal intensive care unit. J Perinatol (2011) 1.40
Airway management in the recovery room. Anaesthesia (1997) 1.39
Enzyme immunoassay with monoclonal antibodies for the detection of rotavirus in stool specimens. J Infect Dis (1985) 1.39
The use of a non-invasive method to measure intrapulmonary shunt during one-lung anaesthesia. Anaesthesia (1996) 1.39
Delayed recovery from general anaesthesia. Anaesthesia (1988) 1.39
Mycoplasma pneumoniae infections and exanthems. J Pediatr (1975) 1.39
Evaluation of a neuraminidase-specific influenza A virus vaccine in children: antibody responses and effects on two successive outbreaks of natural infection. J Infect Dis (1979) 1.38
Hepatitis G virus infection in hemodialysis patients and the effects of interferon treatment. Am J Gastroenterol (1997) 1.38